Trial Profile
Phase II Trial Of Perifosine In Locally Advanced, Unresectable Or Metastatic Pancreatic Adenocarcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jul 2013
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Jul 2013 New trial record